Call to Action – Save the OMMP
CALL TO ACTION ▪ SAVE OMMP Talking points – HB 2198 ♦ Committee targets OMMP growers! ♦ Requires OLCC licenses! ♦ OLCC limits patient access to medicine! Act Now! ♦ Call the Committee and tell them STOP THE INTEGRATION. ♦ New amendments create Uncertainty for Patients. Oppose the “dash ones†and support...
Cannabis as Stigmatized Medicine
In a article published in the February 2013, Harm Reduction Journal  entitled, “Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study” authors Joan L Bottorff, Laura JL Bissell, Lynda G Balneaves, John L Oliffe, N Rielle Capler and Jane Buxton, state, “Experiences of stigma among those with illness and the role stigma plays in seeking treatment are not new...
Chron’s Disease & Cannabis
Treatment of Crohn’s Disease with Cannabis: An Observational Study Timna Naftali MD1, Lihi Bar Lev BA2, Doron Yablekovitz MD1, Elisabeth Half MD1 and Fred M. Konikoff MD1 In a recent study and the first of its kind, Cannabis has been show in this small sampling to benefit those...
Medical Marijuana Laws Reduce Prescription Medication Use In Medicare Part D
In a study by Ashley C. Bradford1 and W. David Bradford2, out of the University of Georgia, it was shown that “national overall reductions in Medicare program and enrollee spending when states implemented medical marijuana laws were estimated to be $165.2 million per year in 2013.” Abstract Legalization of medical marijuana has been...
McLean Hospital Study Finds That Medical Marijuana Use May Improve Cognitive Performance
A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function Preliminary evidence from a new study led by McLean Hospital’s Staci Gruber, PhD, director of the Marijuana Investigations for Neuroscientific Discovery (MIND) program, suggests that medical marijuana may not impair, and in many cases, may actually...
Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
In a 2014 report of a study conducted by Marcus A. Bachhuber, MD; Brendan Saloner, PhD; Chinazo O. Cunningham, MD, MS to “determine the association between the presence of state medical cannabis laws and opioid analgesic overdose mortality,” they wrote, “increased access to medical cannabis may reduce opioid analgesic use by patients with chronic pain, and...
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
In a March 18, 2016 report, the Center for Disease Control (CDC) released its guidelines on Prescribing Opioids for Chronic Pain. In this article, the CDC cautions clinicians in testing for substances “for which results would not affect patient management.” “Clinicians should not test for substances for which results would not...
Patients, Growers, and Caregivers. What HB 3400 means to you.
We are pleased to present our synopsis of the changes to the Oregon Medical Marijuana Program made by House Bill 3400. We have published it on our website so that you can download it for your files. We are asking all clinics and dispensaries to notify patients and growers...
Limited Study Shows Promise for Idiopathic Recurrent Angioedema
(This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.*) Â Abstract We present a case of a 27-year-old man with recurrent episodes of angioedema since he was 19, who...
Cannabidiol Protects Liver
Reprinted without permission Free Radic Biol Med. 2014 Mar;68:260-7. doi: 10.1016/j.freeradbiomed.2013.12.026. Epub 2014 Jan 4. Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. . Abstract Acute alcohol drinking induces steatosis, and effective prevention of steatosis can protect liver from...